For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.63 in the prior trading day, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $1.57, down -3.68%. In other words, the price has decreased by -$3.68 from its previous closing price. On the day, 1.54 million shares were traded.
Ratios:
Our goal is to gain a better understanding of RVPH by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.39 and its Current Ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on September 20, 2023, initiated with a Buy rating and assigned the stock a target price of $12.
On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.
On January 24, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on January 24, 2022, with a $10 target price.
Stock Price History:
Over the past 52 weeks, RVPH has reached a high of $4.45, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -17.52%, while the 200-Day Moving Average is calculated to be 10.55%.
Shares Statistics:
A total of 46.58M shares are outstanding, with a floating share count of 41.47M. Insiders hold about 10.96% of the company’s shares, while institutions hold 22.12% stake in the company.
